Year Established :
2007
Total Assets(USD) :
More than 99,999,999
Total Number of Staff :
50-100
Main Competitive Advantages :
International Approvals/Standards,Experienced R&D Staff,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Quality Service
Other Competitive Advantages :
Quality products and services are derived from Enantiotech staff's unremitting pursuitof excellence and customer satisfaction.
Enantiotech is your strategic partner of chiral molecules.
Business Type :
Manufacturer
R&D Capacity :
OEM,ODM
Annual Turnover(USD) :
500,000 to 99,999,999
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Range :
1. API& Related Intermediates: Aprepitant, Apremilast, Solifenacin, Ezetimibe, Vonoprazan fumarate, Avibactam, KPT330 Selinexor, Lorlatinib ext.
2. Chiral Molecules: Amino acids; Chiral dicarboxylic acids; Chiral alcohols; Chiral ligands.
3. Proprietary ligands & catalysts.
4. Featured